These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 11843256

  • 1. Hand-foot syndrome associated with short infusions of combination chemotherapy with gemcitabine and vinorelbine.
    Laack E, Mende T, Knuffmann C, Hossfeld DK.
    Ann Oncol; 2001 Dec; 12(12):1761-3. PubMed ID: 11843256
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: potential for decreased toxicity and combination with biological therapy.
    Herbst RS, Khuri FR, Lu C, Liu DD, Fossella FV, Glisson BS, Pisters KM, Shin DM, Papadimitrakopoulou VA, Kurie JM, Blumenschein G, Kies MS, Zinner R, Jung MS, Lu R, Lee JJ, Munden RF, Hong WK, Lee JS.
    Cancer; 2002 Jul 15; 95(2):340-53. PubMed ID: 12124835
    [Abstract] [Full Text] [Related]

  • 7. Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma: Phase II trials of the Minnie Pearl Cancer Research Network.
    Hainsworth JD, Burris HA, Billings FT, Bradof JE, Baker M, Greco FA.
    Cancer; 2001 Nov 01; 92(9):2391-8. PubMed ID: 11745295
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Activity and toxicity of gemcitabine and gemcitabine + vinorelbine in advanced non-small-cell lung cancer elderly patients: Phase II data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trial.
    Gridelli C, Cigolari S, Gallo C, Manzione L, Ianniello GP, Frontini L, Ferraù F, Robbiati SF, Adamo V, Gasparini G, Novello S, Perrone F, MILES Investigators.
    Lung Cancer; 2001 Nov 01; 31(2-3):277-84. PubMed ID: 11165408
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A phase I trial of fixed dose rate gemcitabine and capecitabine in metastatic renal cell carcinoma.
    Rini BI, Weinberg V, Small EJ.
    Cancer; 2005 Feb 01; 103(3):553-8. PubMed ID: 15612026
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer: a phase II trial.
    Laack E, Mende T, Dürk H, Kneba M, Dickgreber N, Welte T, Müller T, Scholtze J, Graeven U, Jasiewicz Y, Edler L, Hossfeld DK.
    Eur J Cancer; 2002 Mar 01; 38(5):654-60. PubMed ID: 11916547
    [Abstract] [Full Text] [Related]

  • 17. Phase I/II study of gemcitabine plus vinorelbine as first-line chemotherapy of non-small-cell lung cancer.
    Lorusso V, Carpagnano F, Frasci G, Panza N, Di Rienzo G, Cisternino ML, Napoli G, Orlando S, Cinieri S, Brunetti C, Palazzo S, De Lena M.
    J Clin Oncol; 2000 Jan 01; 18(2):405-11. PubMed ID: 10637256
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
    Clegg A, Scott DA, Sidhu M, Hewitson P, Waugh N.
    Health Technol Assess; 2001 Jan 01; 5(32):1-195. PubMed ID: 12065068
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.